Literature DB >> 20360244

Community incidence of norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis.

Gemma Phillips1, Clarence C Tam, Stefano Conti, Laura C Rodrigues, David Brown, Miren Iturriza-Gomara, Jim Gray, Ben Lopman.   

Abstract

Existing estimates of the incidence of infectious intestinal disease (IID) caused by norovirus are based on electron microscopy or reverse transcription-polymerase chain reaction (RT-PCR). Neither method accurately represents norovirus disease burden: Electron microscopy has poor diagnostic sensitivity, and RT-PCR has poor diagnostic specificity. In this study, viral load measurements were used to identify cases of norovirus-associated IID and to produce new incidence estimates for England. IID cases were ascertained in the Study of Infectious Intestinal Disease in England (1993-1996), and stool specimens were tested by semiquantitative real-time RT-PCR for norovirus. The age-adjusted community incidence of norovirus-associated IID was 4.5/100 person-years (95% credibility interval: 3.8, 5.2), equating to 2 million episodes/year. Among children aged less than 5 years, the community incidence was 21.4/100 person-years (95% credibility interval: 15.9, 27.7), and the incidence of consultations to general practitioners for norovirus-associated IID was 3.2/100 person-years (95% credibility interval: 2.6, 3.8), with 100,000 children visiting their general practitioner for norovirus-associated IID each year. Norovirus is the most common cause of IID in the community in England and is responsible for a similar number of pediatric primary care consultations as rotavirus.

Entities:  

Mesh:

Year:  2010        PMID: 20360244     DOI: 10.1093/aje/kwq021

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  64 in total

Review 1.  Norovirus Illnesses in Children and Adolescents.

Authors:  Minesh P Shah; Aron J Hall
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

2.  Norovirus Loads in Stool Specimens of Cancer Patients with Norovirus Gastroenteritis.

Authors:  Taojun He; Tracy A McMillen; Yuanyuan Qiu; Liang Hua Chen; Xuedong Lu; Xiao-Li Pang; Mini Kamboj; Yi-Wei Tang
Journal:  J Mol Diagn       Date:  2017-08-12       Impact factor: 5.568

3.  Transmission routes of rare seasonal diseases: the case of norovirus infections.

Authors:  Stephen P Rushton; Roy A Sanderson; William D K Reid; Mark D F Shirley; John P Harris; Paul R Hunter; Sarah J O'Brien
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-08       Impact factor: 6.237

4.  Enteropathogens in acute diarrhea: a general practice-based study in a Nordic country.

Authors:  I Hilmarsdóttir; G E Baldvinsdóttir; H Harðardóttir; H Briem; S I Sigurðsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-05       Impact factor: 3.267

5.  The Clinical and Economic Burden of Norovirus Gastroenteritis in the United States.

Authors:  Sarah M Bartsch; Kelly J O'Shea; Bruce Y Lee
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

6.  The potential economic value of a human norovirus vaccine for the United States.

Authors:  Sarah M Bartsch; Benjamin A Lopman; Aron J Hall; Umesh D Parashar; Bruce Y Lee
Journal:  Vaccine       Date:  2012-09-28       Impact factor: 3.641

7.  Targeting macrophage- and intestinal epithelial cell-specific microRNAs against norovirus restricts replication in vivo.

Authors:  Lucy Thorne; Jia Lu; Yasmin Chaudhry; Dalan Bailey; Ian Goodfellow
Journal:  J Gen Virol       Date:  2018-04-23       Impact factor: 3.891

8.  Infectivity of GII.4 human norovirus does not differ between T-B-NK+ severe combined immunodeficiency (SCID) and non-SCID gnotobiotic pigs, implicating the role of NK cells in mediation of human norovirus infection.

Authors:  Thavamathi Annamalai; Zhongyan Lu; Kwonil Jung; Stephanie N Langel; Christopher K Tuggle; Jack C M Dekkers; Emily H Waide; Sukumar Kandasamy; Linda J Saif
Journal:  Virus Res       Date:  2019-05-02       Impact factor: 3.303

Review 9.  Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children.

Authors:  Daniel C Payne; Umesh D Parashar; Benjamin A Lopman
Journal:  Curr Opin Pediatr       Date:  2015-02       Impact factor: 2.856

10.  Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination options.

Authors:  Molly K Steele; Justin V Remais; Manoj Gambhir; John W Glasser; Andreas Handel; Umesh D Parashar; Benjamin A Lopman
Journal:  Epidemics       Date:  2016-10-24       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.